Treatment of a patient with type 3 von Willebrand disease and alloantibody against von Willebrand factor

被引：0
|
作者：
Halimeh, S. [1 ]
Faeser, B. [1 ]
Budde, U. [2 ]
Laws, H. [3 ]
Rott, H. [1 ]
机构：
[1] MVZ Lab Duisburg GmbH, Duisburg, Germany
[2] Aescu Lab, Hamburg, Germany
[3] Univ Hosp, Dusseldorf, Germany
来源：
HAEMOPHILIA | 2010年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：149 / 149
页数：1
相关论文
共 50 条
  • [1] von Willebrand factor alloantibodies in type 3 von Willebrand disease
    Kotnik, Barbara Faganel
    Strandberg, Karin
    Debeljak, Marusa
    Kitanovski, Lidija
    Jazbec, Janez
    Benedik-Dolnicar, Majda
    Bakija, Alenka Trampus
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2020, 31 (01) : 77 - 79
  • [2] AN ALLOANTIBODY TO VON-WILLEBRAND-FACTOR SELECTIVELY INHIBITING THE BINDING OF VON-WILLEBRAND-FACTOR TO COLLAGEN IN A PATIENT WITH SEVERE VON-WILLEBRAND DISEASE
    BUDDE, U
    EFFENBERGER, W
    OLDENBURG, J
    SCHNEPPENHEIM, R
    VANGENDEREN, P
    DREWKE, E
    BRACKMANN, HH
    [J]. THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1161 - 1161
  • [3] Alloantibody from a patient with severe von Willebrand disease inhibits von Willebrand factor-FVIII interaction
    Batlle, J
    Loures, E
    Vila, P
    Hernandez, MC
    Mendez, JA
    Torea, J
    Rendal, E
    Couselo, MJ
    Filgueira, A
    Lopez, MF
    Fernandez
    [J]. ANNALS OF HEMATOLOGY, 1997, 75 (03) : 111 - 115
  • [4] Alloantibody from a patient with severe von Willebrand disease inhibits von Willebrand factor-FVIII interaction
    J. Batlle
    E. Lourés
    P. Vila
    M. C. Hernández
    J. A. Méndez
    J. Torea
    E. Rendal
    M. J. Couselo
    A. Filgueira
    M. F. López Fernández
    [J]. Annals of Hematology, 1997, 75 : 111 - 115
  • [5] Treatment of acute haemorrhage in a patient with type 3 von Willebrand's disease and alloantibodies against von Willebrand factor with recombinant activated factor VII
    Dietrich A.
    Scholz U.
    Schreiter D.
    [J]. European Surgery, 2005, 37 (6) : 336 - 339
  • [6] Von Willebrand factor inhibitors developed in type 3 von Willebrand disease
    Megdiche, F.
    Kassar, O.
    Hdiji, S.
    Mbarek, L.
    Charfi, M.
    Elloumi, M.
    Kallel, C.
    [J]. HAEMOPHILIA, 2019, 25 : 87 - 87
  • [7] von Willebrand disease and von Willebrand factor
    Sadler, Brooke
    Castaman, Giancarlo
    O'Donnell, James S.
    [J]. HAEMOPHILIA, 2022, 28 : 11 - 17
  • [8] von Willebrand Factor and von Willebrand Disease
    王兆钺
    [J]. 血栓与止血学, 2005, (04) : 147 - 149
  • [9] VON WILLEBRAND FACTOR INHIBITORS IN TYPE 3 VON WILLEBRAND DISEASE: CHALLENGES IN DIAGNOSIS
    Megdiche, F.
    Kassar, O.
    Krichen, I.
    Kallel, F.
    Ghorbel, M.
    Elloumi, M.
    Kallel, C.
    [J]. HAEMOPHILIA, 2020, 26 : 135 - 135
  • [10] BINDING OF VON-WILLEBRAND-FACTOR TO FACTOR-VIII IS INHIBITED BY AN ALLOANTIBODY FROM A PATIENT WITH SEVERE VON-WILLEBRAND DISEASE
    BATLLE, J
    FERNANDEZ, MFL
    LOURES, E
    BOSCH, N
    LOPEZ, MJB
    [J]. THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1181 - 1181
12345